Cargando…
Sphingolipids in Atherosclerosis: Chimeras in Structure and Function
Atherosclerosis—a systemic inflammatory disease—is the number one cause of mortality and morbidity worldwide. As such, the prevention of disease progression is of global interest in order to reduce annual deaths at a significant scale. Atherosclerosis is characterized by plaque formation in the arte...
Autores principales: | Peters, Lisa, Kuebler, Wolfgang M., Simmons, Szandor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9570378/ https://www.ncbi.nlm.nih.gov/pubmed/36233252 http://dx.doi.org/10.3390/ijms231911948 |
Ejemplares similares
-
Extracellular vesicles as regulators of kidney function and disease
por: Behrens, Felix, et al.
Publicado: (2020) -
Bacterial Membrane Vesicles in Pneumonia: From Mediators of Virulence to Innovative Vaccine Candidates
por: Behrens, Felix, et al.
Publicado: (2021) -
Potential therapeutic targets for atherosclerosis in sphingolipid metabolism
por: Yu, Zemou, et al.
Publicado: (2019) -
The Complex Tail of Circulating Sphingolipids in Atherosclerosis and Cardiovascular Disease
por: Zelnik, Iris D., et al.
Publicado: (2021) -
On Top of the Alveolar Epithelium: Surfactant and the Glycocalyx
por: Ochs, Matthias, et al.
Publicado: (2020)